These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 8096155)

  • 21. Understanding drug resistance for monotherapy treatment of HIV infection.
    Kirschner DE; Webb GF
    Bull Math Biol; 1997 Jul; 59(4):763-85. PubMed ID: 9214852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of HIV concentration during acute infection: independence from a specific immune response.
    Phillips AN
    Science; 1996 Jan; 271(5248):497-9. PubMed ID: 8560262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
    Le Guern M; Levy JA
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):363-7. PubMed ID: 1346069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stochastic Dynamics of the Latently Infected Cell Reservoir During HIV Infection.
    Azoz SA; Coombs D
    Bull Math Biol; 2019 Jan; 81(1):131-154. PubMed ID: 30298198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of replicative fitness on competing HIV strains.
    Chirove F; Lungu EM
    Biosystems; 2013 Jul; 113(1):28-36. PubMed ID: 23623939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses.
    Walker CM; Thomson-Honnebier GA; Hsueh FC; Erickson AL; Pan LZ; Levy JA
    Cell Immunol; 1991 Oct; 137(2):420-8. PubMed ID: 1680028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals.
    Hsueh FW; Walker CM; Blackbourn DJ; Levy JA
    Cell Immunol; 1994 Dec; 159(2):271-9. PubMed ID: 7994759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus dynamics model with intracellular delays and immune response.
    Song H; Jiang W; Liu S
    Math Biosci Eng; 2015 Feb; 12(1):185-208. PubMed ID: 25811332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractional Dynamics of HIV with Source Term for the Supply of New CD4
    Shah Z; Jan R; Kumam P; Deebani W; Shutaywi M
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33806939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.
    Haase AT
    Annu Rev Immunol; 1999; 17():625-56. PubMed ID: 10358770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-specific CD8+ T-cell immune responses and viral replication.
    Buseyne F; Rivière Y
    AIDS; 1993 Nov; 7 Suppl 2():S81-5. PubMed ID: 7909230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection.
    Frost SD; McLean AR
    AIDS; 1994 Mar; 8(3):323-32. PubMed ID: 7913327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
    Chun TW; Engel D; Berrey MM; Shea T; Corey L; Fauci AS
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8869-73. PubMed ID: 9671771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hopf bifurcation in a CTL-inclusive HIV-1 infection model with two time delays.
    Wang J; Qin CY; Chen YM; Wang X
    Math Biosci Eng; 2019 Mar; 16(4):2587-2612. PubMed ID: 31137229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
    Holm GH; Gabuzda D
    J Virol; 2005 May; 79(10):6299-311. PubMed ID: 15858014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of isolate-specific neutralizing activity is correlated with an increased viral burden in rapidly progressing HIV-1-infected patients.
    Lu W; Shih JW; Tourani JM; Eme D; Alter HJ; Andrieu JM
    AIDS; 1993 Nov; 7 Suppl 2():S91-9. PubMed ID: 7909232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.